In the News

News Outlets Taking Notice of CND Life Sciences’ NIH Grant Award

By November 16, 2020 December 16th, 2020 No Comments

News Outlets Taking Notice of CND Life Sciences’ NIH Grant Award 

News of CND Life Sciences’ $2.4 million grant from the National Institutes of Health is generating interest in news outlets for both healthcare professionals and patients. 

The grant will be used to enhance the precision and utility of the Syn-One Test™, a simple and minimally invasive skin test that aids in the diagnosis of synucleinopathies such as Parkinson’s disease and dementia with Lewy bodies.  

Read CND Co-Founder Dr. Todd Levine’s interview in NeurologyLive here.

See the coverage in Parkinson’s News Today here.

CND Life Sciences

CND Life Sciences

CND Life Sciences is the creator of the Syn-One Test™, the world’s first commercially available test to visualize abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. The test is an objective, evidence-based diagnostic tool to aid in the diagnosis of Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, pure autonomic failure, or REM sleep behavior disorder.